1. Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients.
- Author
-
Lee JG, Park I, Lee H, Nam S, Kim J, Lee WS, Kang M, and Kim JH
- Subjects
- Humans, Female, Male, Prognosis, Middle Aged, Aged, Antigens, CD metabolism, Adult, Aged, 80 and over, Disease-Free Survival, Cadherins metabolism, Colorectal Neoplasms pathology, Colorectal Neoplasms mortality, Colorectal Neoplasms metabolism, Neoplasm Staging, Biomarkers, Tumor metabolism
- Abstract
Purpose: This study aimed to investigate the clinical significance of E-cadherin expression levels in colorectal cancer tissues and explore the relationship between E-cadherin expression and tumor node metastasis (TNM) stage. The goal was to establish a more accurate prognostic prediction for colorectal cancer patients by analyzing E-cadherin expression levels alongside TNM staging., Methods: The study examined colorectal cancer patients by dividing them into groups based on E-cadherin expression levels. It then assessed their 5-year event-free survival (EFS) and disease-specific survival (DSS) hazard ratios (HRs). Additionally, the prognosis of patients was analyzed by combining E-cadherin expression levels with TNM staging, particularly focusing on patients in stages III and IV., Results: The E-cadherin
Low group had significantly worse outcomes, with HRs of 2.30 for EFS and 2.76 for DSS compared to the E-cadherinHigh group. When combined with TNM stage III/IV, patients with E-cadherinLow expression showed a poor prognosis, with HRs of 1.93 for EFS and 2.35 for DSS compared to those with E-cadherinHigh expression at the same TNM stage., Conclusions: Low levels of E-cadherin expression are associated with a poor prognosis and decreased survival in colorectal cancer patients. Combining E-cadherin expression levels with TNM staging provides a more precise prediction of patient prognosis and survival, potentially guiding personalized treatment strategies., Competing Interests: Declarations. Ethical approval: All methods were carried out in accordance with relevant guidelines and regulations. Ethical approval for study was obtained from Institutional Review Board of Gachon University Gil Medical Center (GBIRB2023-224). Informed consent was obtained from all the participants. Consent for publication: All participants involved in the study have provided written informed consent for the publication of anonymized data and findings derived from the research. The authors affirm that no identifiable personal information or sensitive data has been included in this publication. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)- Published
- 2025
- Full Text
- View/download PDF